##### 



EXHIBIT
10.1
 LIMITED LIABILITY COMPANY OWNERSHIP INTEREST
PURCHASE AGREEMENT
 BY AND AMONG
 ARCADIA RESOURCES, INC.
(ARCADIA or BUYER),
 PRAIRIESTONE PHARMACY, LLC
(COMPANY)
 AND
 AMERISOURCEBERGEN DRUG CORPORATION,
LUNDS, INC,
LFHI RX, LLC,
MARVIN R. RICHARDSON,
JOHN J. BRADY,
&
LEWIS P. ZEIDNER
(SELLERS)
 January 28, 2007




---



##### 



TABLE OF CONTENTS
 PageARTICLE I SALE AND TRANSFER OF UNITS; CLOSING
    
    
    11.1 Sale and Purchase of Units
    
    
    11.2 Purchase Price
    
    
    11.3 Definitions
    
    
    21.4 Closing Date Consideration
    
    
    21.5 Price Adjustment
    
    
    21.6 Anniversary Date Consideration
    
    
    21.7 Earn-Out Consideration
    
    
    31.8 Payment of Purchase Price
    
    
    61.9 Uncollected Accounts Receivable
    
    
    91.10 Closing
    
    
    91.11 Closing Obligations
    
    
    91.12 Payoff of ABDC Term Note
    
    
    111.13 Sale of Arcadia Shares by Executive Sellers to Satisfy Tax Obligations
    
    
    111.14 Controlled Sales of Arcadia Shares by Sellers
    
    
    121.15 Existing AutoMed Agreement
    
    
    131.16 Purchase Price Allocation
    
    
    14ARTICLE II REPRESENTATIONS AND WARRANTIES OF SELLERS
    
    
    142.1 Organization, Existence and Good Standing
    
    
    142.2 Power, Authority and Enforceability of the Company
    
    
    152.3 Power, Authority and Enforceability of Sellers
    
    
    152.4 No Conflict
    
    
    152.5 Capitalization
    
    
    152.6 Subsidiaries
    
    
    162.7 Financial Statements
    
    
    162.8 Books and Records
    
    
    162.9 Title to Properties; Encumbrances
    
    
    172.10 Real Property
    
    
    172.11 Condition and Sufficiency of Assets
    
    
    172.12 Accounts Receivable
    
    
    182.13 Inventory
    
    
    182.14 No Undisclosed Liabilities
    
    
    182.15 Taxes
    
    
    182.16 Bank Accounts
    
    
    192.17 Employee Benefits
    
    
    192.18 Compliance with Legal Requirements
    
    
    212.19 Governmental Authorizations
    
    
    222.20 Legal Proceedings; Orders
    
    
    22
 i




---



##### 



Page2.21 Absence of Certain Changes and Events
    
    
    232.22 Contracts; No Defaults
    
    
    242.23 Material Adverse Changes
    
    
    262.24 Insurance
    
    
    272.25 Environmental Matters
    
    
    272.26 Employees/Representatives
    
    
    282.27 Labor Relations; Compliance
    
    
    282.28 Intellectual Property
    
    
    292.29 Finders or Broker Fees
    
    
    312.30 Competitive Interest
    
    
    312.31 Related Party Transactions
    
    
    312.32 Related Party Obligations
    
    
    312.33 Name; Prior Transactions
    
    
    322.34 Permits
    
    
    322.35 Litigation and Claims
    
    
    322.36 Decrees, Orders or Arbitration Awards
    
    
    322.37 Securities Laws
    
    
    322.38 Disclaimer of Other Representations or Warranties
    
    
    35ARTICLE III REPRESENTATIONS AND WARRANTIES OF BUYER
    
    
    353.1 Organization, Existence and Good Standing
    
    
    353.2 Authority; No Conflict
    
    
    353.3 Certain Proceedings
    
    
    363.4 Arcadia Documents
    
    
    36ARTICLE IV COVENANTS OF COMPANY AND SELLERS
    
    
    374.1 Access and Investigation
    
    
    374.2 Operation of the Business of Each Acquired Company
    
    
    374.3 Requirement; Approvals
    
    
    384.4 Notification
    
    
    384.5. Acquired Companies Indebtedness
    
    
    384.5 No Solicitation or Negotiation
    
    
    384.6 Agreement to Payoff AutoMed Equipment Leases
    
    
    394.7 Best Efforts
    
    
    394.8 Audited Company Financial Statements
    
    
    39ARTICLE V COVENANTS OF BUYER PRIOR TO CLOSING DATE
    
    
    395.1 Approvals of Governmental Bodies
    
    
    395.2 Best Efforts
    
    
    39ARTICLE VI CONDITIONS PRECEDENT TO BUYERS OBLIGATION TO CLOSE
    
    
    39
 ii




---



##### 



Page6.1 Accuracy of Representations
    
    
    406.2 Minimum Average Share Price
    
    
    406.3 AMEX Approval for Issuance of Arcadia Shares
    
    
    406.4 Sellers Performance
    
    
    406.5 Consents
    
    
    406.6 Additional Documents
    
    
    406.7 No Proceedings
    
    
    416.8 No Claim Regarding Unit Ownership or Sale Proceeds
    
    
    416.9 No Prohibition
    
    
    416.10 Resignation of Directors and Officers
    
    
    416.11 Termination of Certain Contracts and Releases of Liability
    
    
    416.12 Closing on Sale of Assets to Lunds
    
    
    416.13 Amended and Restated Loan Agreement
    
    
    41ARTICLE VII CONDITIONS PRECEDENT TO OBLIGATION OF COMPANY AND THE SELLERS TO CLOSE
    
    
    427.1 Accuracy of Representations
    
    
    427.2 Buyers Performance
    
    
    427.3 Additional Documents
    
    
    427.4 No Injunction
    
    
    427.5 AMEX Approval for Issuance of Arcadia Shares
    
    
    43ARTICLE VIII TERMINATION
    
    
    438.1 Termination Events
    
    
    438.2 Effect of Termination
    
    
    43ARTICLE IX INDEMNIFICATION, REMEDIES AND POST CLOSING COVENANTS
    
    
    449.1 Survival; Right to Indemnification Not Affected by Knowledge
    
    
    449.2 Indemnification and Payment of Damages by the Company and Sellers
    
    
    449.3 Indemnification and Payment of Damages by Buyer
    
    
    459.4 Termination of Obligations of Company
    
    
    469.5 Survival of Representations and Warranties
    
    
    469.6 Buyer Indemnification Limitations
    
    
    469.7 Claims
    
    
    479.8 Third Party Claims
    
    
    479.9 Other Claims
    
    
    479.10 Payments
    
    
    489.11 Appointment of Sellers Committee
    
    
    489.12 Authority
    
    
    489.13 Reliance
    
    
    499.14 Indemnification of Sellers Committee
    
    
    50
 iii




---



##### 



PageARTICLE X DEFINITIONS
    
    
    5010.1Accounts Receivable
    
    
    5010.2Acquired Companies
    
    
    5010.3Acquired Company
    
    
    5010.4Affiliate
    
    
    5010.5Agreement
    
    
    5010.6Best Efforts
    
    
    5010.7Breach
    
    
    5010.8Buyer
    
    
    5110.9Buyers Advisors
    
    
    5110.10 Buyers Closing Documents
    
    
    5110.11 Closing
    
    
    5110.12 Closing Date
    
    
    5110.13 Code
    
    
    5110.14 Control, Controls and Controlled
    
    
    5110.15 Company Assets
    
    
    5110.16 Consent or Consents
    
    
    5110.17 Contemplated Transactions
    
    
    5110.18 Contract
    
    
    5110.19 Damages
    
    
    5210.20 Delinquent Accounts Receivable
    
    
    5210.21 Employee Benefit Plan
    
    
    5210.22 Encumbrance
    
    
    5210.23 Environment
    
    
    5210.24 Environmental, Health, and Safety Liabilities
    
    
    5210.25 Environmental Law
    
    
    5310.26 ERISA
    
    
    5310.27 Exempt Damages
    
    
    5310.28 Exempt Provisions
    
    
    5310.29 Facilities
    
    
    5310.30 Fiduciary
    
    
    5410.31 Financial Statements
    
    
    5410.32 GAAP
    
    
    5410.33 Governmental Authorization
    
    
    5410.34 Governmental Body
    
    
    5410.35 Hazardous Activity
    
    
    5410.36 Hazardous Materials
    
    
    5410.37 Indebtedness
    
    
    5410.38 Indemnified Persons
    
    
    5410.39 Intellectual Property
    
    
    5410.40 Intellectual Property Assets
    
    
    5510.41 Interim Financial Statements
    
    
    5510.42 IRC
    
    
    5510.43 IRS
    
    
    5510.44 Knowledge
    
    
    55
 iv




---



##### 



Page10.45 Leased Property
    
    
    5510.46 Legal Requirement
    
    
    5510.47 Liability
    
    
    5510.48 Limitation
    
    
    5510.49 Material Adverse Change (or Effect)
    
    
    5510.50 Occupational Safety and Health Law
    
    
    5610.51 Order
    
    
    5610.52 Ordinary Course of Business
    
    
    5610.53 Organizational Documents
    
    
    5610.54 Person
    
    
    5610.55 Proceeding
    
    
    5610.56 Purchase Price
    
    
    5610.57 Records
    
    
    5610.58 Release
    
    
    5710.59 Sale Transaction
    
    
    5710.60 Seller or Sellers
    
    
    5710.61 Sellers Closing Documents
    
    
    5710.62 Sellers Noncompetition Agreement
    
    
    5710.63 Sellers Releases
    
    
    5710.64 Subsidiary
    
    
    5710.65 Tax
    
    
    5710.66 Tax Return
    
    
    5710.67 Threat of Release
    
    
    5810.68 Threatened
    
    
    5810.69 Units
    
    
    58ARTICLE XI GENERAL PROVISIONS
    
    
    5811.1 Confidentiality
    
    
    5811.2 Obligations of Sellers
    
    
    5811.3 Expenses
    
    
    5811.4 Schedules
    
    
    5911.5 Public Announcements
    
    
    5911.6 Notices
    
    
    5911.7 Certain Taxes
    
    
    6111.8 Recoupment
    
    
    6111.9 Further Assurances
    
    
    6111.10 Waiver
    
    
    6111.11 Entire Agreement and Modification
    
    
    6211.12 Construction
    
    
    6211.13 Assignments; Successors; No Third Party Rights
    
    
    6211.14 Severability
    
    
    6311.15 Headings
    
    
    6311.16 Time of Essence
    
    
    6311.17 Governing Law
    
    
    6311.18 Arms Length Negotiations
    
    
    63
 v




---



##### 



Page11.19 Counterparts/Facsimile Signatures
    
    
    6311.20 Attorney-Client Privilege
    
    
    63
 vi




---



##### 



LIMITED LIABILITY COMPANY OWNERSHIP INTEREST
 PURCHASE AGREEMENT
 THIS LIMITED LIABILITY COMPANY OWNERSHIP INTEREST PURCHASE AGREEMENT Arcadia Resources, Inc PrairieStone Pharmacy, LLC, AmerisourceBergen Drug Corporation Lunds, Inc LFHI Rx, LLC Marvin R. Richardson, John J. Brady Lewis P. Zeidner
 RECITALS :
    AGREEMENT
 NOW, THEREFORE,
 ARTICLE I
SALE AND TRANSFER OF UNITS; CLOSING
 1.1 Sale and Purchase of Units .
 1.2 Purchase Price.




---



##### 



1.3 Definitions.
 1.3.1
 1.3.2
 1.3.3
 1.3.4
 1.3.5
 1.3.6
 1.3.7
 1.3.8
 1.4 Closing Date Consideration
 1.5 Price Adjustment
 1.6 Anniversary Date Consideration.
 2




---



##### 



1.6.1
    1.6.2
    1.7 Earn-Out Consideration .
 1.7.1
 3




---



##### 



1.7.2
 1.7.3
 1.7.4
 1.7.5
 4




---



##### 



1.7.6
 5




---



##### 



1.8 Payment of Purchase Price .
 1.8.1 Non Executive Sellers Closing Date Consideration.
 1.8.2 Executive Sellers Closing Date Consideration.
 Definitions.
    6




---



##### 



Allocation of Holdback Account.
 Holdback Share Rights.
 Creating the Holdback Account.
 Quarterly Adjustments.
 7




---



##### 



Release of Holdback Shares to the Executive Sellers.
 1.8.3
 1.8.4
  8




---



##### 



1.9 Uncollected Accounts Receivable .
 1.10 Closing .
 1.11 Closing Obligations .
 1.11.1
 9




---



##### 



10




---



##### 



1.11.2
     1.12 Payoff of ABDC Term Note .
 1.13 Sale of Arcadia Shares by Executive Sellers to Satisfy Tax Obligations.
 11




---



##### 



1.14 Controlled Sales of Arcadia Shares by Sellers.
 1.14.1
 12




---



##### 



1.14.2
 1.15 Existing AutoMed Agreement.
 1.15.1
 1.15.2
    13




---



##### 



1.15.3
 1.16 Purchase Price Allocation.
 ARTICLE II
REPRESENTATIONS AND WARRANTIES OF SELLERS
  2.1 Organization, Existence and Good Standing .
 14




---



##### 



2.2 Power, Authority and Enforceability of the Company .
 2.3 Power, Authority and Enforceability of Sellers .
 2.4 No Conflict .
 2.5 Capitalization .
 15




---



##### 



2.6 Subsidiaries .
 2.7 Financial Statements .
 2.8 Books and Records .
 16




---



##### 



2.9 Title to Properties; Encumbrances .
 2.10 Real Property.
 2.10.1
 2.10.2
      2.11 Condition and Sufficiency of Assets .
 17




---



##### 



2.12 Accounts Receivable .
 2.13 Inventory .
 2.14 No Undisclosed Liabilities .
 2.15 Taxes .
 2.15.1
 2.15.2
 18




---



##### 



2.15.3
 2.15.4
 2.15.5
 2.15.6
 2.15.7
 2.15.8
 2.16 Bank Accounts .
 2.17 Employee Benefits .
 2.17.1
 2.17.2
 19




---



##### 



2.17.3
 2.17.4
 2.17.5
 2.17.6
 2.17.7
 2.17.8
 20




---



##### 



2.17.9
 2.17.10
 2.17.11
 2.18 Compliance with Legal Requirements .
 2.18.1
 2.18.2
 2.18.3
 2.18.4
 2.18.5
 21




---



##### 



2.18.6
 2.19 Governmental Authorizations .
 2.19.1
 2.19.2
 2.19.3
 2.20 Legal Proceedings; Orders .
 22




---



##### 



2.20.1
 2.20.2
 2.21 Absence of Certain Changes and Events .
 2.21.1
 2.21.2
 2.21.3
 2.21.4
 2.21.5
 2.21.6
 2.21.7
 23




---



##### 



2.21.8
 2.21.9
 2.21.10
 2.21.11
 2.21.12
 2.21.13
 2.21.14
 2.21.15
 2.21.16
 2.21.17
 2.21.18
 2.21.19
 2.22 Contracts; No Defaults
 24




---



##### 



25




---



##### 



2.22.2
 2.22.3
     2.23 Material Adverse Changes .
 26




---



##### 



2.24 Insurance .
 2.25 Environmental Matters .
 2.25.1
 2.25.2
 2.25.3
 27




---



##### 



2.26 Employees/Representatives .
 2.26.1
 2.26.2
 2.26.3
 2.26.4
 2.26.5
 2.27 Labor Relations; Compliance .
 28




---



##### 



2.28 Intellectual Property .
 2.28.1
 2.28.2
 2.28.3
  29




---



##### 



2.28.4
 2.28.5
 2.28.6
 2.28.7
 2.28.8
 2.28.9
 2.28.10
 30




---



##### 



2.28.11
 2.28.12
 2.29 Finders or Broker Fees .
 2.30 Competitive Interest .
 2.31 Related Party Transactions .
 2.32 Related Party Obligations .
 31




---



##### 



2.33 Name; Prior Transactions .
 2.34 Permits .
 2.35 Litigation and Claims .
 2.36 Decrees, Orders or Arbitration Awards .
 2.37 Securities Laws .
 2.37.1
 2.37.2
 2.37.3
 32




---



##### 



2.37.4
 2.37.5
 2.37.6
 2.37.7
 33




---



##### 



2.37.8
 2.37.9
 2.37.10
 2.37.11
 2.37.12
 2.37.13
 34




---



##### 



2.37.14
 2.38 Disclaimer of Other Representations or Warranties.
 ARTICLE III
REPRESENTATIONS AND WARRANTIES OF BUYER
  3.1 Organization, Existence and Good Standing .
 3.2 Authority; No Conflict .
 3.2.1
 35




---



##### 



3.2.2
      3.3 Certain Proceedings .
 3.4 Arcadia Documents .
 3.4.1
 3.4.2
 3.5 Authorization of Arcadia Shares.
 36




---



##### 



ARTICLE IV
COVENANTS OF COMPANY AND SELLERS
  4.1 Access and Investigation .
 4.2 Operation of the Business of Each Acquired Company .
 4.2.1
 4.2.2
 4.2.3
 4.2.4
 4.2.5
 4.2.6
 4.2.7
 37




---



##### 



4.2.8
 4.3 Requirement; Approvals .
 4.4 Notification .
 4.5 Acquired Companies Indebtedness.
 4.5 No Solicitation or Negotiation.
 38




---



##### 



4.6 Agreement to Payoff AutoMed Equipment Leases .
 4.7 Best Efforts .
 4.8 Audited Company Financial Statements .
 ARTICLE V
COVENANTS OF BUYER PRIOR TO CLOSING DATE
  5.1 Approvals of Governmental Bodies .
 5.2 Best Efforts .
 ARTICLE VI
CONDITIONS PRECEDENT TO BUYERS OBLIGATION TO CLOSE
  39




---



##### 



6.1 Accuracy of Representations .
 6.2 Minimum Average Share Price.
 6.3 AMEX Approval for Issuance of Arcadia Shares .
 6.4 Sellers Performance .
 6.4.1
 6.4.2
 6.5 Consents.
 6.6 Additional Documents .
 6.6.1
 6.6.2
 6.6.3
 40




---



##### 



6.7 No Proceedings .
 6.8 No Claim Regarding Unit Ownership or Sale Proceeds .
 6.9 No Prohibition .
 6.10 Resignation of Directors and Officers .
 6.11 Termination of Certain Contracts and Releases of Liability .
 6.12 Closing on Sale of Assets to Lunds.
 6.13 Amended and Restated Loan Agreement.
 6.14 De Lage Landen Financial Services Lease Agreement.
 6.15 Release of Liens
 41




---



##### 



ARTICLE VII
CONDITIONS PRECEDENT TO OBLIGATION OF
COMPANY AND THE SELLERS TO CLOSE
  7.1 Accuracy of Representations .
 7.2 Buyers Performance .
 7.2.1
 7.2.2
 7.3 Additional Documents .
 7.3.1
 7.3.2
 7.4 No Injunction.
 42




---



##### 



7.5 AMEX Approval for Issuance of Arcadia Shares .
 7.6 De Lage Landen Financial Services Lease Agreement.
 7.7 Amended and Restated Loan Agreement .
 ARTICLE VIII
TERMINATION
 8.1 Termination Events .
 8.1.1
 8.1.2
 8.1.3
 8.1.4
 8.2 Effect of Termination .
 43




---



##### 



ARTICLE IX
INDEMNIFICATION, REMEDIES AND POST CLOSING COVENANTS
 9.1 Survival; Right to Indemnification Not Affected by Knowledge .
 9.2 Indemnification and Payment of Damages by the Company and Sellers
 9.2.1
 9.2.2
 9.2.3
 9.2.4
 9.2.5
 44




---



##### 



9.2.6
 9.2.7
 9.2.8
 9.2.9
 9.2.10
 9.2.11
 9.3 Indemnification and Payment of Damages by Buyer .
 45




---



##### 



9.4 Termination of Obligations of Company .
 9.5 Survival of Representations and Warranties .
 9.6 Buyer Indemnification Limitations .
 46




---



##### 



9.7 Claims
 9.8 Third Party Claims
 9.9 Other Claims.
 9.9.1
 9.9.2
 9.9.3
 47




---



##### 



9.10 Payments
 9.11 Appointment of Sellers Committee .
 9.12 Authority .
        48




---



##### 



9.13 Reliance .
      49




---



##### 



9.14 Indemnification of Sellers Committee .
 ARTICLE X
DEFINITIONS
  10.1 Accounts Receivable
 10.2 Acquired Companies
 10.3 Acquired Company
 10.4 Affiliate
 10.5 Agreement
 10.6 Best Efforts
 10.7 Breach
 50




---



##### 



10.8 Buyer
 10.9 Buyers Advisors
 10.10 Buyers Closing Documents
 10.11 Closing
 10.12 Closing Date
 10.13 Code
 10.14 Control, Controls and Controlled
 10.15 Company Assets
 10.16 Consent or Consents
 10.17 Contemplated Transactions
 10.17.1
 10.17.2
 10.17.3
 10.17.4
 10.17.5
 10.18 Contract
 51




---



##### 



10.19 Damages
 10.20 Delinquent Accounts Receivable
 10.21 Employee Benefit Plan
 10.22 Encumbrance
 10.23 Environment
 10.24 Environmental, Health, and Safety Liabilities
 10.24.1
 10.24.2
 52




---



##### 



10.24.3
 10.24.4
 10.24.5
  10.25 Environmental Law
 10.26 ERISA
 10.27 Exempt Damages
 10.28 Exempt Provisions
 10.29 Facilities
 53




---



##### 



10.30 Fiduciary
 10.31 Financial Statements
 10.32 GAAP
 10.33 Governmental Authorization
 10.34 Governmental Body
 10.35 Hazardous Activity
 10.36 Hazardous Materials
 10.37 Indebtedness
 10.38 Indemnified Persons
 10.39 Intellectual Property
 54




---



##### 



10.40 Intellectual Property Assets
 10.41 Interim Financial Statements
 10.42 IRC
 10.43 IRS
 10.44 Knowledge
 10.45 Leased Property
 10.46 Legal Requirement
 10.47 Liability
 10.48 Limitation
 10.49 Material Adverse Change (or Effect)
 55




---



##### 



10.50 Occupational Safety and Health Law
 10.51 Order
 10.52 Ordinary Course of Business
 10.53 Organizational Documents
 10.54 Person
 10.55 Proceeding
 10.56 Purchase Price
 10.57 Records
 56




---



##### 



10.58 Release
 10.59 Sale Transaction
 10.60 Seller or Sellers
 10.61 Sellers Closing Documents
 10.62 Sellers Noncompetition Agreement
 10.63
Sellers Releases
 10.64 Subsidiary
 10.65 Tax
 10.66 Tax Return
 57




---



##### 



10.67 Threat of Release
 10.68 Threatened
 10.69
Units
 ARTICLE XI
GENERAL PROVISIONS
 11.1 Confidentiality .
 11.2 Obligations of Sellers .
 11.3 Expenses .
 58




---



##### 



11.4 Schedules .
 11.5 Public Announcements .
 11.6 Notices .
 Company:
    
    PrairieStone Pharmacy, LLC2800 Campus Drive Suite 30Plymouth, Minnesota 55441Attn: PresidentFax No.(763) 746-7778With a copy to:
    
    Fredrikson & Byron, P.A.200 South Sixth StreetMinneapolis, Minnesota 55402Attn: Neil A. WeikartFax No. (612) 492-7077Sellers:
    
    Marvin R. Richardson14888 Pondview CircleWayzata, Minnesota 55391
 59




---



##### 



John J. Brady7928 Preservation Drive,Indianapolis, Indiana 46278Lewis P. Zeidner5400 Union Terrace LanePlymouth, Minnesota 55442With a copy to:
    
    Anthony Ostlund & Baer, PA3600 Well Fargo center90 South Seventh StreetMinneapolis, Minnesota 55402Attn: Norman BaerFax No. (612) 349-6996Sellers:
    
    Lunds, Inc.4100 West 50th StreetEdina, Minnesota 55424Attn: PresidentFax No (952) 915-2675Lunds Rx, LLC4100 West 50th StreetEdina, Minnesota 55424Attn: PresidentFax No (952) 915-2675With a copy to:
    
    Rider Bennett, LLP33 South Sixth StreetSuite 4900Minneapolis, Minnesota 55402Attn: Gene H. HennigFax No. (612) 337-7568Seller:
    
    AmerisourceBergen Drug Corporation1300 Morris DriveChesterbrook, Pennsylvania 19087-5594Attn: PresidentFax No. (610) 727-3601With a copies to:
    
    Eckert Seamans Cherin & Mellott, LLCTwo Liberty Place50 South 16th Street, 22nd FloorPhiladelphia, Pennsylvania 19102Attn: Gary A. Miller
 60




---



##### 



Fax No. (215) 851-8383AndAmerisourceBergen Drug Corporation1300 Morris DriveChesterbrook, Pennsylvania 19087-5594Attn: General CounselFax No. (610) 727-3612Buyer:
    
    Arcadia, Inc405 5th Avenue South, Suite 6Naples, Florida 34102Attn: President and CEOFax No.: (239) 434-5858With a copy to:
    
    Kerr, Russell and Weber, PLC500 Woodward Avenue, Suite 2500Detroit, Michigan 48226Attn: Patrick J. HaddadFax No. (313) 961-0388
 11.7 Certain Taxes .
 11.8 Recoupment .
 11.9 Further Assurances .
 11.10 Waiver.
 61




---



##### 



11.11 Entire Agreement and Modification .
 11.12 Construction .
 11.13 Assignments; Successors; No Third Party Rights .
 62




---



##### 



11.14 Severability .
 11.15 Headings .
 11.16 Time of Essence .
 11.17 Governing Law .
 11.18 Arms Length Negotiations .
 11.19 Counterparts/Facsimile Signatures .
 11.20 Attorney-Client Privilege.
 11.21 Dispute Resolution
 63




---



##### 



[Signatures appear on the following pages.]
 64




---



##### 



[One
of Two Signature pages to Limited Liability Company Ownership Interest Purchase Agreement.]
  BUYER:Arcadia Resources,
Inc.,a Nevada CorporationBy:
    
    /s/ John E. Elliott, IIIts:
    
    Chairman and CEOCOMPANY:PrairieStone Pharmacy, LLC,a Delawarelimited liability companyBy:
    
    /s/ Marvin R. RichardsonIts:
    
    President and CEOSELLERS:AmerisourceBergen Drug Corporation,a Delaware corporation,By:
    
    /s/ John G. ChouIts:
    
    Vice President and SecretaryLunds, Inc.,a Minnesota corporation,By:
    
    /s/ Russell T. Lund, IIIIts:
    
    Chairman and CEOLFHI Rx, LLC,a Minnesota limited liability company,By:
    
    /s/ Russell T. Lund, IIIIts:
    
    President
 65




---



##### 



[Two of Two Signature pages to Limited Liability Company Ownership Interest Purchase
Agreement.]
 /s/ Marvin R. RichardsonMARVIN R. RICHARDSON/s/ John J. BradyJOHN J. BRADY/s/ Lewis P. ZeidnerLEWIS P. ZEIDNERAutoMed:AutoMed Technologies, Inc., 
as to Section 1.15 only.By:
    /s/ John G. ChouIts:
    Vice President and Secretary
 66